VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 72 filers reported holding VOR BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $389,638 | +3.8% | 389,638 | +146.0% | 0.00% | – |
Q1 2024 | $375,389 | +93.8% | 158,392 | +152.7% | 0.00% | – |
Q2 2023 | $193,712 | +8749.3% | 62,690 | -84.6% | 0.00% | -100.0% |
Q1 2023 | $2,189 | -33.9% | 406,851 | -18.3% | 0.00% | -50.0% |
Q4 2022 | $3,312 | -99.8% | 498,080 | +47.0% | 0.00% | +100.0% |
Q3 2022 | $1,349,000 | -6.1% | 338,921 | +17.3% | 0.00% | 0.0% |
Q2 2022 | $1,436,000 | +1336.0% | 288,942 | +1639.3% | 0.00% | – |
Q1 2022 | $100,000 | -70.8% | 16,613 | -9.4% | 0.00% | – |
Q2 2021 | $342,000 | – | 18,339 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $6,361,723 | 1.42% |
RA Capital Management | 22,748,880 | $22,748,880 | 0.30% |
JOHNSON & JOHNSON | 1,074,658 | $1,074,658 | 0.27% |
Paradigm Biocapital Advisors LP | 6,457,293 | $6,457,293 | 0.25% |
Sarissa Capital Management LP | 618,000 | $618,000 | 0.10% |
Laurion Capital Management LP | 2,525,449 | $2,525,449 | 0.03% |
Ground Swell Capital, LLC | 20,674 | $20,674 | 0.02% |
Point72 Asia (Singapore) Pte. Ltd. | 63,262 | $63,262 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 132,298 | $132,298 | 0.01% |
MAI Capital Management | 470,068 | $470,068 | 0.01% |